Merit Medical: Global Operations Leadership Transition; COO Role Eliminated

What Happened
Merit Medical Systems, Inc. announced a reorganization of its global operations on August 14, 2026 that eliminated the Chief Operating Officer position. As part of that change, Neil W. Peterson’s title was changed to Senior Advisor and he delivered written notice on August 18, 2026 that he will resign for “good reason” effective March 5, 2027. Effective August 31, 2026, Merit appointed Sheri L. Lewis as Executive Vice President of Global Operations. Ms. Lewis joins from Skin Health Systems and previously held senior operations roles at Avantor Sciences, Medtronic and Honeywell; she is 60 years old and holds a B.A. in Organizational Management from Concordia University.

Key Details

• Employment Agreement effective August 31, 2026 (filed as Exhibit 10.1): base salary $600,000 and a $400,000 signing bonus.
• Bonus and equity: eligible for Merit’s 2026 annual bonus (target 60% of base salary, pro‑rated for 2026; max 200% of base) and participation in Merit’s 2026 Equity Incentive Plan (award eligibility set by the Compensation and Talent Committee).
• Termination pay (non‑change‑of‑control): Merit must pay accrued amounts plus, if Merit terminates without cause or Ms. Lewis resigns for good reason, a lump sum equal to the greater of (i) her annual base salary or (ii) three‑week salary × completed years of service (capped at 26 years). She is also entitled to a pro‑rata portion of performance stock units for the applicable period.
• Change‑of‑control treatment: if termination is in connection with a change in control, Merit must pay two times the sum of (i) base salary and (ii) the average annual bonus for the last three full fiscal years, and provide target performance stock unit shares without regard to performance or vesting.

Why It Matters
This filing signals a material leadership and organizational change in Merit’s global operations — eliminating the COO role and installing a new senior operations executive. For investors, key takeaways are the potential near‑term personnel and cash impacts: an immediate $400,000 signing bonus, ongoing salary and bonus commitments, and possible severance/accelerated equity liabilities if Ms. Lewis’s employment ends or a change of control occurs. The employment agreement defines concrete financial obligations that could affect cash flow or compensation expense depending on future events.